MRKON
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.
Ime in priimek MRKON
Uvrstitev No.3565
Tržna kapitalizacija $0.00
Popolnoma razredčena tržna kapitalizacija $0.00
Tržni delež %
Volumen trgovanja/tržna kapitalizacija (24h) 1,953,694.52%
Razpoložljivi obtok 51.08246944
Največja ponudba 0
Skupna ponudba 51.08246944
Hitrost kroženja %
Datum izdaje --
Cena, po kateri je bilo sredstvo prvič izdano --
Najvišja vrednost vseh časov 131.37596799777506, 2026-05-30
Najnižja cena 106.19666406291768, 2026-01-29
Javna veriga blokov MRKON
Uvod Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.
Panoga
Družbeni mediji
Analiza pretoka sredstev
|
Nakup(MRKON) |
Prodaja(MRKON) |
Neto dotok |
| Velik |
-- |
-- |
-- |
| Srednji |
-- |
-- |
-- |
| Majhen |
-- |
-- |
-- |
| Skupaj |
-- |
-- |
-- |
etfindex:mc_etfindex_source Omejitev odgovornosti: Podatke zagotavlja cmc in se ne smejo obravnavati kot naložbeni nasveti.
